Skip to content
Axe Capital logo Axe Capital Trading News

Prediction: 3M Will Reward Patient Investors

2026-10-26 09:15 •Lee Samaha •The Motley Fool Positive Axe Cap view: Selective •Equities•Earnings •MMM•FAST

Axe Cap view

3M’s Turnaround Takes Patience but Shows Promise

3M’s operational improvements point to long-term value, despite heavy legal costs looming.

3M is carving a path back to growth under CEO Bill Brown, with organic sales gaining momentum and a hefty pipeline of new products set to drive future revenues. The recent upgrade to their 2026 earnings outlook confirms these efforts are bearing fruit. Trading at roughly 18 times free cash flow, 3M looks reasonably priced, especially for a company of this scale and diversity. However, investors should brace for significant legal settlements related to environmental and product liabilities that will weigh on cash flow in 2027 and 2028. This means short-term patience is key; the near-term hit to earnings might test nerves before the turnaround story plays out. There isn’t a perfect local JSE stock to match 3M’s industrial transformation, but watch how USD/ZAR moves as global risk appetite fluctuates—it often mirrors overseas industrial sentiment. The view could falter if new product launches underperform or if unexpected liabilities balloon beyond current estimates. this is just our opinion and not financial advice

How I would invest

For patient investors, accumulate selectively and hold through near-term noise while monitoring global industrial cues and USD/ZAR trends. Avoid chasing 3M if seeking quick returns.

What I would watch
  • MMM
  • USD/ZAR
What could go wrong
  • Higher-than-expected legal settlements
  • Slower-than-anticipated sales growth
How strongly I feel

6/10

3M is showing operational improvements under CEO Bill Brown with accelerating organic sales growth and strong new product introductions (350 NPIs expected in 2026). The company upgraded its 2026 earnings guidance and maintains an attractive valuation at 18.4x price-to-FCF. However, significant legal settlement payments of $2.6 billion in 2027 and $1.6 billion in 2028 related to PFAS contamination and combat arms earplugs litigation will pressure near-term cash flow, making patience necessary for long-term investors.

Our take is based on reporting first published by The Motley Fool.

Read the original story